COVID-19 in hematological malignancy patients: A protocol for a systematic review and meta-analysis

BACKGROUND: COVID-19 is an international outbreak of the respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The diseases themselves, as well as the intensity of chemotherapy, lead to significant immunosuppression, leading hematological malignancy patients sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Can, Weng, Qianping, Li, Yiwei, Shi, Pengfei, Qian, Shenxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458179/
https://www.ncbi.nlm.nih.gov/pubmed/32871864
http://dx.doi.org/10.1097/MD.0000000000021376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458179/
https://www.ncbi.nlm.nih.gov/pubmed/32871864
http://dx.doi.org/10.1097/MD.0000000000021376

Ejemplares similares